Hepatic Veno-occlusive Disease
📧 Sign up to get email alerts when something new happens for Hepatic Veno-occlusive Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2023-12-20EMA Authorised: Defitelio (defibrotide) — Gentium S.r.l.
Defitelio (defibrotide) has been authorised by the EMA for hepatic veno-occlusive disease, with Gentium S.r.l. as the marketing authorizatio…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update on Antithrombin-III for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
-
CLINICAL_TRIALS withdrawal · 2020-01-13Clinical Trial Update: Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients [Phase 4]
A Phase 4 clinical trial validating ultrasound biomarkers for hepatic sinusoidal obstruction syndrome in pediatric hematopoietic cell transp…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study [Phase 3]
This document reports the completion and results posting of a Phase 3 Treatment IND study of defibrotide for hepatic veno-occlusive disease,…
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver
Clinical trial update describing compassionate-use access to defibrotide for patients with hepatic veno-occlusive disease of the liver.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients [Phase 3]
Phase 3 trial evaluating defibrotide for the treatment of severe hepatic veno-occlusive disease in hematopoietic stem cell transplant patien…
-
FDA approval · 2016-03-30FDA Approved: DEFITELIO — Original Application (Jazz Pharmaceuticals, Inc.)
The FDA approved Defibrotide (Defitelio) as the original application for the treatment of hepatic veno-occlusive disease in adults and child…
-
CLINICAL_TRIALS research · 2014-07-01Clinical Trial Update: Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
Clinical trial update on compassionate-use access to defibrotide for life-threatening hepatic veno-occlusive disease; the trial is no longer…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide [Phase 2, Phase 3]
A completed pediatric Phase 2/3 trial evaluated prophylactic defibrotide to assess incidence and outcomes of hepatic veno-occlusive disease.
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: Effects on Glutamine on the Outcome of Allogeneic Bone Marrow Transplant Recipients [NA]
An update on a clinical trial evaluating the effect of glutamine on outcomes in allogeneic bone marrow transplant recipients, with associate…